Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 7, Pages 6028
Publisher
MDPI AG
Online
2023-03-23
DOI
10.3390/ijms24076028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platinum-based drugs for cancer therapy and anti-tumor strategies
- (2022) Chunyu Zhang et al. Theranostics
- A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
- (2022) Philipp Fronik et al. Communications Chemistry
- Glucose transporters GLUT1, GLUT3, and GLUT4 have different effects on osteoblast proliferation and metabolism
- (2022) Milja Arponen et al. Frontiers in Physiology
- The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
- (2021) Chang Liu et al. Frontiers in Oncology
- Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
- (2021) Eoin Moynihan et al. Frontiers in Chemistry
- AKT but not MYC promotes reactive oxygen species-mediated cell death in oxidative culture
- (2020) Dongqing Zheng et al. JOURNAL OF CELL SCIENCE
- Structure, function and regulation of mammalian glucose transporters of the SLC2 family
- (2020) Geoffrey D. Holman PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
- (2020) Sandra Valle et al. Nature Communications
- Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
- (2020) Anja Charlotte Lundgren Mortensen et al. Frontiers in Oncology
- Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche
- (2020) Giada Bassi et al. Scientific Reports
- Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
- (2019) Reece G. Kenny et al. CHEMICAL REVIEWS
- Differences in osteogenic induction of human mesenchymal stem cells between a tailored 3D hybrid scaffold and a 2D standard culture
- (2019) Samuele M. Dozio et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Evaluation of different crosslinking agents on hybrid biomimetic collagen-hydroxyapatite composites for regenerative medicine
- (2018) Gopal Shankar Krishnakumar et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties in vitro and in vivo
- (2018) Jing Ma et al. Frontiers in Chemistry
- Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo
- (2017) Jing Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery
- (2017) Jing Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
- (2017) Marie-Françoise Heymann et al. CELLULAR IMMUNOLOGY
- Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents
- (2016) Qingpeng Wang et al. DALTON TRANSACTIONS
- Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects
- (2016) Jing Ma et al. DALTON TRANSACTIONS
- Chemical Approach to Positional Isomers of Glucose–Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo
- (2016) Malay Patra et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Screening out irrelevant cell-based models of disease
- (2016) Peter Horvath et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors
- (2016) Kapil Upadhyaya et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(iv) prodrug with unique mode of action
- (2015) Lili Ma et al. CHEMICAL COMMUNICATIONS
- Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
- (2014) Rasheena Edmondson et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Crystal structure of the human glucose transporter GLUT1
- (2014) Dong Deng et al. NATURE
- Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
- (2012) Linfeng Sun et al. NATURE
- Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells
- (2011) Manuel Cifuentes et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Satraplatin: leading the new generation of oral platinum agents
- (2009) Ashish Bhargava et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started